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AbstrACt
Introduction There are little published data on the long-
term psychological outcomes in intensive care unit (ICU) 
survivors and their family members in Australian ICUs. In 
addition, there is scant literature evaluating the effects of 
psychological morbidity in intensive care survivors on their 
family members. The aims of this study are to describe 
and compare the long-term psychological outcomes of 
intubated and non-intubated ICU survivors and their family 
members in an Australian ICU setting.
Methods and analysis This will be a prospective 
observational cohort study across four ICUs in Australia. The 
study aims to recruit 150 (75 intubated and 75 non-intubated) 
adult ICU survivors and 150 family members of the survivors 
from 2015 to 2018. Long-term psychological outcomes 
and effects on health-related quality of life (HRQoL) will be 
evaluated at 3 and 12 months follow-up using validated 
and published screening tools. The primary objective is to 
compare the prevalence of affective symptoms in intubated 
and non-intubated survivors of intensive care and their 
families and its effects on HRQoL. The secondary objective 
is to explore dyadic relations of psychological outcomes in 
patients and their family members.
Ethics and dissemination The study has been approved 
by the relevant human research ethics committees 
(HREC) of Australian Capital Territory (ACT) Health 
(ETH.11.14.315), New South Wales (HREC/16/HNE/64), 
South Australia (HREC/15/RAH/346). The results of this 
study will be published in a peer-reviewed medical journal 
and presented to the local intensive care community and 
other stakeholders.
trial registration number ACTRN12615000880549; Pre-
results.
IntroduCtIon 
Over the last two decades, numerous long-
term-outcome studies have shown that 
survivors of critical illnesses can suffer from 
a complex, myriad of health and socio-eco-
nomic issues, long after discharge from 
hospital.1–6 Initial seminal studies on long-
term outcomes in critical illnesses are based 
on survivors of Acute Respiratory Distress 
Syndrome (ARDS), a condition tradition-
ally treated with invasive ventilation, seda-
tion and muscle relaxants.7–10 Long-term 
(1 to 5 years) outcomes of acute lung injury 
and ARDS survivors have been extensively 
studied,11 12 with emerging evidence of long-
term follow-up outcomes in other categories 
of intensive care unit (ICU) survivors.3 13 14 
The term ‘Post Intensive Care Syndrome’ was 
framed to describe new or worsening impair-
ments in physical, cognitive or mental health 
status developing after an episode of critical 
illness and persisting beyond discharge.15 
Based on the above research, it has been 
established, beyond reasonable doubt, that a 
significant proportion of ICU survivors expe-
rience long-term psychological consequences, 
including post-traumatic stress disorder (PTSD), 
strengths and limitations of this study
 ► Largest Australian long-term follow-up study in in-
tensive care survivors and family members.
 ► Study includes non-intubated intensive care unit 
(ICU) patient population, as their outcomes have 
previously not been vigorously studied.
 ► Study design includes dyads of ICU survivors and 
family members to explore interdependence of ad-
verse outcomes.
 ► The tools adopted to assess psychological and 
health-related quality of life (HRQoL) outcomes are 
published and validated.
 ► A significant limitation of the study design is the ab-
sence of pre-ICU admission data on HRQoL, prevent-
ing comparisons with post-ICU outcomes.
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anxiety and depression.16–20 The reported prevalence of 
adverse neuropsychiatric outcomes in intensive care survi-
vors varies across studies. A recent systematic review of the 
literature from 2008 to 2012 suggests that up to 27% of ICU 
survivors suffer from PTSD.21 On the other hand, another 
recent study from the USA found that the prevalence of 
PTSD in ICU survivors was 16% at 3 months post ICU.22 A 
systematic review of the literature reveals that the reported 
prevalence of anxiety in ICU survivors ranges from 23% to 
48% and 17% to 43% for depression.19 Another study shows 
an incidence of 31% for depressive symptoms, post ICU.22 
Literature review suggests that the severity of illness as 
evidenced by the need for intubation, mechanical ventila-
tion and sedation is an important risk factor for psycholog-
ical stress in ICU survivors.23–26 However, there is very little 
literature on the incidence of psychological stress, post- ICU, 
in patients who do not need sedation, intubation or mechan-
ical ventilation. Interventions to reduce PTSD in ICU survi-
vors have excluded the less severe patient populations (not 
intubated and ventilated).27 It is possible the incidence of 
psychological symptoms in such a population is low, but this 
remains only a conjecture.
Published literature also suggests that a high proportion of 
family members of intensive care patients are left with varying 
psychological symptoms that can include anxiety, depression 
and PTSD.28–31 Some of the possible precipitating factors 
impacting the family’s psychological state include a concern 
for the nature of the patient's critical illness, perception of 
inadequate communication in the ICU, lack of adequate 
understanding of the patient’s illness, concerns about the 
patient’s prognosis, surrogate decision making on end-of-life 
care and the prospect of providing continuing care to survi-
vors.29 32 33
Family members and ICU survivors can essentially be 
considered a dyad and interactions between the dyads could 
have an influence on the physical and psychological health 
and health-related quality of life (HRQoL) outcomes of 
both.34 The emotional interdependence between ICU survi-
vors and their spouses has been studied in a subset of adult 
sepsis and chronic critically-ill survivors.35 36
To date, there is little data from Australian ICUs about the 
prevalence of psychological stress in ICU survivors and their 
family members. Drawing comparisons between prevalence 
rates across the continents from studies predominantly origi-
nating in America and Europe may not be helpful due to the 
variation in critical care services.37 In addition, emotional 
interdependence of dyads of ICU survivors and their family 
members have not been previously studied in a diverse 
group of ICU survivors and family members.
The primary aim of this multicentre study is to determine 
and compare the prevalence of affective symptoms in intu-
bated and non-intubated ICU survivors and family members 
by screening them for PTSD, anxiety, depression and 
HRQoL over a 12-month follow-up period. The secondary 
aims are to explore the dyadic relations of psychological 
outcomes in patients and their family members.
We anticipate that the Psychological stRess in Intensive 
CarE survivors (PRICE) study will provide significant insight 
into the impact of affective symptoms on post-intensive-care 
survivors, especially the non-intubated groups and their 
family members as they have been previously excluded from 
studies. This will contribute to the existing body of knowl-
edge, especially the interdependence between survivors and 
their family members.
MEthods And AnAlysIs
study design
PRICE is a multicentre, prospective, observational cohort 
study reviewing ICU survivors and their family members. The 
groups will be formed based on the following ICU admission 
characteristics: a) Intubated group: intubated ICU survivor 
and family member, b) Non-intubated group: non-intubated 
ICU survivor and family member.
setting
The study will be conducted in four ICUs in Australia: The 
Canberra Hospital, Australian Capital Territory; Nepean 
Hospital and John Hunter Hospital, New South Wales and 
Royal Adelaide Hospital, South Australia. All the four ICUs 
are part of large public teaching hospitals. Local principal 
investigators, in conjunction with local research teams, will 
conduct the trial in their respective hospitals. It is estimated 
that the study will take 3 years (2015–2018) to complete 
recruitment and follow-up.
study population
The study population will include adult (18 years and older) 
ICU survivors and their family members who have been 
discharged from the ICU during the study period. Detailed 
inclusion and exclusion criteria are as follows:
ICU survivors
Inclusion criteria
A. Intubated ICU survivor:
 – Able to provide valid, informed consent after ICU 
discharge.
 – Intubated and mechanically ventilated for more 
than 24 hours.
 – Stayed in the ICU for more than 72 hours.
B. Non-intubated ICU survivor:
 – Able to provide valid, informed consent after ICU 
discharge.
 – Not intubated during current ICU stay.
 – Received inotropic/vasopressor support and/or 
non-invasive ventilation during ICU stay.
Exclusion criteria
 ► Prior history of a psychiatric disorder/s in patient 
(psychotic disorders, chronic PTSD).
 ► Imminent death/palliative care patient (unlikely to 
be alive at follow-up at 3, 12 months).
 ► Suspected acute primary brain lesion that may result 
in global impairment of consciousness or cognition, 
such as traumatic brain injury, intracranial haemor-
rhage, stroke or hypoxic brain injury.
 ► Unable to give informed consent prior to hospital 
discharge.
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 ► Non-English speaking background.
Family members
Inclusion criteria
 ► Family member (spouse/partner/next of kin/lives 
with patient normally) of a consenting ICU patient 
with the above criteria.
 ► Age 18 years and older.
Exclusion criteria
 ► Refusal of consent from the associated ICU survivor 
(as detailed below).
 ► Unable to give informed consent prior to hospital 
discharge.
 ► Non-English speaking background.
Patients will be screened for eligibility by the research 
staff in the participating ICUs after discharge from the 
ICU. Research staff will approach medical and nursing 
teams in the hospital wards to seek their permission 
to approach the patients and also to confirm that the 
patients are not delirious and can provide appropriate 
consent. Absence of delirium will also be confirmed by 
reviewing the ward medical and nursing notes for the 
previous 24–48 hours before approaching the patients. 
Only patients with concerns about unresolved delirium 
in the hospital will be excluded.
Hospital records for patients will be checked for next 
of kin details and this will be confirmed from the patient. 
Patients and family members will be explained about the 
study and provided with the appropriate study information 
sheet (online supplementary appendix 1 and 2). Opportu-
nities will be given for follow-up questions prior to seeking 
study consent. The consent form (online supplementary 
appendix 3 and 4) will have an option for the participants 
to only participate in a postal follow-up survey. Consenting 
patients included in the study will have follow-up assess-
ments, even if the family member declines to participate. 
Consenting family members will not be recruited if the 
patient declines to participate, as it will not be possible to 
gather patient demographic data without patient consent. 
Those enrolled will also be encouraged to contact the prin-
cipal researcher at any time if they need further clarifica-
tion on any aspects of the study.
Follow-up
The initial (baseline) assessments with consenting 
patients and families will be conducted in-hospital 
after ICU discharge using validated screening tools as 
described below. Patient and family member contact 
details (name, mailing address, contact numbers) will 
be collected to enable contact for the 3 and 12 months’ 
assessments. If a participant is lost to follow-up at 3 months, 
they will continue to be included in the study until the 
next follow-up at 12 months. Participant follow-up will 
include postal and phone follow-ups. Hospital databases 
will be screened to obtain information to confirm their 
discharge from hospital and any recorded death of the 
patients before attempting to contact the participants. In 
the event of a recorded patient death, no attempt will be 
made to contact participating families in an attempt to 
avoid distress. If hospital records indicate that the patient 
continues to be a hospital in-patient or has been re-ad-
mitted to hospital during the designated follow-up time 
period, researchers will meet with him/her personally 
to check his/her well-being and deliver the assessment 
tools. Participants will be considered lost to follow-up if 
neither 3 or 12-month follow-up data is available. If the 
patient or the family member revoke consent, they will be 
withdrawn from the study and neither the patient nor the 
family member will be approached about the study again.
Figure 1 shows the planned assessment tools and inter-
vals for data collection with details of the screening tools 
to be used as follows.
screening tools
Post-Traumatic Stress Syndrome-14 (PTSS-14) is a 14-item 
screening tool to identify patients at risk of suffering 
PTSD in ICUs.38 39 PTSS-14, although not a diagnostic 
tool, is a self-reporting screening tool; each item is rated 
1 (never) to 7 (always) with a total score ranging from 14 
to 98 (online supplementary appendix 5).
Impact of Event Scale–Revised (IES-R), has 22 ques-
tions to better capture the DSM-IV criteria for PTSD40 41 
(online supplementary appendix 6). The tool, though not 
diagnostic for PTSD, is an appropriate instrument to 
measure the subjective response to a specific traumatic 
event, especially in the response sets of intrusion (intru-
sive thoughts, nightmares, intrusive feelings and imagery, 
dissociative-like re-experiencing), avoidance (numbing 
of responsiveness, avoidance of feelings, situations and 
ideas), and hyperarousal (anger, irritability, hypervigi-
lance, difficulty concentrating, heightened startle).
Depression and Anxiety Stress Scales-21 (DASS-21) 
is a screening tool for identifying, differentiating and 
Figure 1 Assessment tools and follow-up intervals. DASS-
21, Depression and Anxiety Stress Scales-21; EQ-5D-5L, 
5-level Health-Related Quality of Life tool (EuroQol group); 
IES-R, Impact of Event Scale-Revised; PTSS-14, Post-
Traumatic Stress Syndrome-14 intensive care screening tool.
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assessing depression, anxiety, and stress.42 DASS-21 
consists of 7 items per scale. DASS allows a way to measure 
the severity of a patient’s core symptoms related to depres-
sion, anxiety and stress (online supplementary appendix 
7). In addition, DASS has Australian normed values for 
drawing comparisons with.
All the above screening tools are short self-administered 
scales, each taking about 3 to 5 min to administer and will 
not overtire patients who could still be weak. Importantly, 
these screening tools are used to assess symptoms of affec-
tive disorders and do not replace a clinician-administered 
diagnostic interview, which needs significant time and 
professional expertise to complete.
The prevalence of PTSD symptoms will be obtained 
by using the PTSS-14 for ICU survivors and IES-R for 
the family members. To screen for anxiety and depres-
sion, DASS-21 tool will be administered to survivors and 
their family members. In addition to the above tools at 3 
and 12 months follow-up, the ICU patient survivors and 
family members will be assessed for their  HRQoL using 
the EQ-5D-5L questionnaire (https:// euroqol. org/ wp- 
content/ uploads/ 2016/ 10/ Sample_ UK__ English__ EQ- 
5D- 5L_ Paper_ Self_ complete_ v1. 0__ ID_ 24700. pdf).
The lead investigator has obtained permission to use 
the questionnaires for the study via e-mail correspon-
dence with Dr Emma Twigg (PTSS-14), Prof Daniel 
Weiss (IES-R) and the EuRoQol Research Foundation 
(EQ-5D-5L), while the DASS-21 tool is freely available.
Managing participant distress
In general terms, the investigators will deal with partici-
pant distress using the LAST approach:
Listen to concerns.
Acknowledge participant’s distress.
Support them by first apologising for raising the matter 
with them and then provide information about seeking 
appropriate counselling.
Thanking the participants for their involvement in the 
study to date.
In the case of distress in study participants at the time of 
the telephone survey, trained ICU research staff will enact 
the above protocol and the study investigators will attempt 
to make contact with the participant within 72 hours to 
ensure their well-being. At this time the distressed partic-
ipants will be advised to see their General Practitioner, 
and they will be re-provided with the contact details of 
their local mental health services should they require 
their help. Further, they will be offered the opportunity 
to have the investigators organise this contact for them, 
if they so wish.
Study participants will not immediately be excluded 
from the study at this stage as they may feel that they will 
benefit from the increased oversight provided by the 
study. However, they will be asked directly if they still 
want to continue in the study. In the case of a refusal 
to continue with the study, the participants will be 
excluded from any further contact by the ICU research 
staff.
data collection
Screening log
A screening log will be maintained to identify reasons for 
non-recruitment and withdrawal of consent.
Baseline data
Once consent is obtained, retrospective chart data will be 
collected as follows:
 ► Demographic data at the time of ICU admission [age, 
sex, Acute Physiology And Chronic Health Evalu-
ation (APACHE) II Score, APACHE III Diagnosis, 
type of ICU admission [trauma/emergency surgical/
medical]).
 ► Duration and type of mechanical ventilation in ICU 
(invasive/non-invasive).
 ► Types of sedative drugs used during ICU stay, espe-
cially use of benzodiazepines and dexmedetomidine.
 ► Record of routine sedation scores used in the partici-
pating ICU (if any).
 ► Record of delirium assessment by Confusion Assess-
ment Method for the ICU scale or any other validated 
tool (if available) during their ICU stay.
 ► Review of new onset antipsychotic medications admin-
istered in the ICU (haloperidol, olanzapine, risperi-
done, quetiapine).
 ► Cumulative fluid balance during ICU stay.
 ► Length of ICU stay.
 ► Length of hospital stay.
 ► Discharge destination from ICU and hospital (home/
rehabilitation hospital/nursing home).
data management and statistical analysis plan
The confidentiality of the participant data will be main-
tained unless disclosure is required by law. Participants 
will not be identified by name, and confidentiality of 
the information derived from medical records will be 
preserved. All data, including paper-based Contact Report 
Form will be stored securely. The electronic database will 
be maintained in a password-protected computer main-
tained on secure government servers.
Power
The primary aim of the study is to characterise the long-
term psychological outcomes (affective symptoms) in 
Australian intensive care survivors and family members. 
The study investigators performed a power calculation 
to compare the difference in prevalence between the 
intubated and non-intubated group. A sample size of 62 
patients in the intubated group and 62 in the non-intu-
bated group will provide 80% power to detect a statisti-
cally significant difference between the two groups, with 
an underlying prevalence of post-ICU affective  symptom 
estimate of 30% and 10% in the intubated and non-intu-
bated populations, respectively, using Χ2  tests at a signif-
icance level of 5%. The estimate rate for the populations 
was based on literature review as described below. Based 
on literature, a potential attrition rate of 20% will be used 
for the 3 and 12-month follow-up and hence, the study 
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will plan to recruit 150 participants (75 patients and 75 
family members) in each of the groups.13 43 44 Sample size 
calculations were performed using Stata V. 12.1.
The prevalence of affective symptoms in ICU survivors 
varies widely between studies based on the screening assess-
ment tools. An assumed prevalence of 30% in the study 
group was based on a broad literature review. The review by 
Davydow et al across several studies revealed a median point 
prevalence of substantial questionnaire-ascertained substan-
tial PTSD symptoms of 22%.25 In another review by Davydow 
et al, the median point prevalence of substantial PTSD symp-
toms in ARDS was 28%.19 In a recent review, Myrhen et al 
showed that a significant proportion of the patients (26.9%) 
had severe PTSD-related symptoms.43 The incidence of 
depressive symptoms in ICU survivors has also been noted to 
be between 28%–30%.22 44
The prevalence of psychological/emotional stress 
varies in the family members of ICU survivors. The inci-
dence of anxiety, PTSD and depression among family 
members of ICU survivors is high at the time of the ICU 
admission of their loved ones, but this decreases post 
discharge, and is variably quoted between 20% and 40% 
in various studies.28 29 32 45 There is no specific literature 
related to psychological outcomes in non-intubated ICU 
patients. Australian population prevalence rates for PTSD 
are approximately 5% and 10% for anxiety and depres-
sion, respectively.46 47 Hence, a composite estimate of 10% 
was used for the non-intubated group.
Statistical analysis plan
Patient demographic and baseline characteristics in the 
two patient cohorts will be summarised using means, 
SD, medians, and 25%–75% quartiles for continuous 
measures and frequencies and percentages for categor-
ical measures. ICU patient survivor outcomes (PTSS-14 
and DASS-21) at baseline and at 3 and 12-month 
follow-ups will be compared between the groups using a 
mixed model analysis. A time by group interaction will 
be tested. Means and standard errors for PTSS-14 and 
DASS-21 scores for each time period and risk group will 
be presented and compared. ICU patient family member 
outcomes using IES-R and DASS-21 will be analysed 
similarly. The EQ-5D-5L evaluates HRQoL using 5-point 
intensity rating scales ranging from ‘none’ to ‘severe’, 
with high scores indicating severe issues in the domain. 
Once the total score has been summed, an algorithm 
will be used to convert the score, consistent with the 
approach used by the scale authors. Index scores will then 
be compared with a UK dataset, as advised and confirmed 
by e-mail correspondence with the EQ-5D-5L Research 
Foundation. For the purposes of the primary outcome, 
missing data would be ignored.
Associations in the prevalence of affective disorders 
between patients and their family members will be 
explored using a modification of an actor-partner-inter-
dependence model. In particular, the plan is to model 
the probability of affective disorders among patients and 
family members at 3 and 12 months using a multilevel 
generalised mixed model, using a nested variance struc-
ture with family unit as a random effect, and family 
member nested within family unit. Covariates of interest 
will include the affective disorder status of patient/family 
members at the preceding time, as well as patient charac-
teristics for example, intubation status.
All analysis will be two-tailed, and p-value <0.05 will 
be considered statistically significant. All analyses will be 
performed using SPSS V. 22.
Patient and public involvement
The PRICE study protocol was reviewed by the local 
human research ethics committees (HREC), which 
routinely have community and consumer representa-
tives. Protocol review by HREC involved community 
views and feedbacks, which contributed to the final study 
protocol. Patients were not involved in the recruitment 
and conduct of the study. Where requested, results will 
be disseminated to the study participants in the form of a 
published manuscript.
EthICs And dIssEMInAtIon
This study will be performed in accordance with the 
ethical principles of the Declaration of Helsinki and 
National Health and Medical Research Council National 
Statement on Ethical Conduct in Research Involving 
Humans (March 2007). The principal investigator will 
ensure adherence to these guidelines. Amendments to 
the study protocol will be submitted for ethical approval. 
The results of this study will be published in a peer-re-
viewed medical journal and presented to the local inten-
sive care community and other stakeholders. 
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